How Is The Market Feeling About Virax Biolabs Group?
Portfolio Pulse from Benzinga Insights
Virax Biolabs Group (NYSE:VRAX) has seen a 9.21% decrease in its short percent of float, now at 5.72%. This indicates a potential shift in market sentiment as fewer shares are being shorted. The company's short interest is higher than its peers, which average 5.16%.
October 28, 2024 | 3:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Virax Biolabs Group's short percent of float has decreased by 9.21%, now at 5.72%, indicating a potential shift in market sentiment. The company's short interest remains higher than its peers.
The decrease in short interest suggests that traders are less bearish on VRAX, which could lead to a positive short-term impact on the stock price. However, the short interest is still higher than its peers, indicating some level of caution remains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100